Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
Soetkin Kennes Hematologie from Gent, company number BE0758586916, closed financial year 2025 with a result of € 120,167 after tax. For that financial year Soetkin Kennes Hematologie recorded a gross margin of € 158,104 and equity of € 127,019. Compared with financial year 2024, the result moved from € 118,873 to € 120,167. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 13, 2026.
€ 127,019
▼ 37% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 120,167
▲ 1% vs 2024
Profit after tax over the fiscal year.
€ 132,845
▼ 27% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 195,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 531
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 75,747 | € 123,797 | € 150,946 | € 158,104 | ▲ 5% |
| Profit after taxes | € 59,138 | € 96,009 | € 118,873 | € 120,167 | ▲ 1% |
| Equity | € 104,620 | € 200,629 | € 201,852 | € 127,019 | ▼ 37% |
| Total debts | € 27,553 | € 49,831 | € 7,062 | € 7,593 | ▲ 8% |
| Cash | € 127,879 | € 245,480 | € 182,326 | € 132,845 | ▼ 27% |
| Retained profit | € 99,620 | € 195,629 | € 196,852 | € 122,019 | ▼ 38% |
| Dividend | € 0 | € 0 | € 117,650 | € 195,000 | ▲ 66% |
| Balance sheet total | € 132,174 | € 250,460 | € 208,914 | € 134,612 | ▼ 36% |
Key figures of Soetkin Kennes Hematologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Soetkin Kennes Hematologie?
What happened at Soetkin Kennes Hematologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 120,167 (▲ 1% vs 2024). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Sint-Niklaas. KBO
In short
From € 59,138 profit in 2022 to € 120,167 profit in 2025.
Paid € 111,955 in corporate taxes since 2022.
Best year ever: 2025, with € 120,167 profit.
Paid out € 312,650 in dividends to the owners in total.
Establishments
Establishment units
Physical locations of this company
Kortrijksesteenweg 674
9000 Gent
Moerlandstraat 1
9100 Sint-Niklaas
Active since 19 November 2020
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- Soetkin Kennes(oprichter) 100%
Details
- Company number
- 0758.586.916
- VAT number
- BE 0758.586.916
- Registered office
- Kortrijksesteenweg 674, 9000 Gent
- Names & denominations
- Soetkin Kennes Hematologie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 November 2020
- Peppol
- Not registered